A detailed history of Clare Market Investments LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Clare Market Investments LLC holds 14,530 shares of NVO stock, worth $1.27 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
14,530
Holding current value
$1.27 Million
% of portfolio
0.3%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$85.0 - $120.04 $1.24 Million - $1.74 Million
14,530 New
14,530 $1.25 Billion
Q3 2024

Feb 20, 2025

BUY
$119.07 - $145.42 $244,569 - $298,692
2,054 Added 38.14%
7,439 $886 Million
Q2 2024

Feb 20, 2025

BUY
$122.71 - $146.91 $187,500 - $224,478
1,528 Added 39.62%
5,385 $769 Million
Q1 2024

Feb 20, 2025

BUY
$102.11 - $135.92 $24,200 - $32,213
237 Added 6.55%
3,857 $495 Million
Q4 2023

Feb 20, 2025

SELL
$87.78 - $105.45 $957,679 - $1.15 Million
-10,910 Reduced 75.09%
3,620 $374 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Clare Market Investments LLC Portfolio

Follow Clare Market Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clare Market Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clare Market Investments LLC with notifications on news.